BG
KMTS

Bellevue Group’s Kestra Medical Technologies KMTS Stock Holding History

Bellevue Group’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.29M Buy
129,215
+13,625
+12% +$285K 0.07% 87
2026
Q1 		$2.3M Sell
115,590
-165
-0.1% -$3.89K 0.05% 77
2025
Q4 		$3.07M Sell
115,755
-12,956
-10% -$334K 0.06% 87
2025
Q3 		$3.06M Sell
128,711
-5,050
-4% -$90.3K 0.06% 86
2025
Q2 		$2.22M Hold
133,761
– – 0.05% 94
2025
Q1 		$3.33M Buy
+133,761
New +$3.07M 0.07% 93

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bellevue Group's KMTS Position: Q2 2026 in Review

Bellevue Group increased its Kestra Medical Technologies (KMTS) stake by 12% in Q2 2026, buying an estimated $285K and bringing the position to 129,215 shares worth $3.29M. The position accounts for 0.07% of the portfolio, ranked #87.

Bellevue Group first reported a position in KMTS in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.33M in Q1 2025. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Bellevue Group held 129,215 shares of Kestra Medical Technologies worth $3.29M as of Q2 2026.
  • Bellevue Group bought 13,625 Kestra Medical Technologies shares in Q2 2026, an estimated $285K.
  • Kestra Medical Technologies made up 0.07% of Bellevue Group's portfolio in Q2 2026, its #87 holding.
  • Bellevue Group first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 6 quarters since.
  • Bellevue Group's Kestra Medical Technologies position peaked at $3.33M in Q1 2025.
  • 109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Bellevue Group's 13F filing for Q2 2026, filed 14 Aug 2026.